Core Viewpoint - Treace Medical Concepts, Inc. is set to showcase new product innovations and present interim data from its clinical studies at the ACFAS Annual Scientific Conference, emphasizing advancements in surgical treatments for bunions and related midfoot deformities [1][2]. Product Innovations - The company will highlight next-generation Lapiplasty instrumentation and fixation technology platforms, including SpeedTMT, Lapiplasty Lightning System, Nanoplasty, Percuplasty, SpeedMTP, and IntelliGuide PSI, aimed at enhancing surgical outcomes and market penetration [2][4]. - SpeedTMT is a new Lapiplasty fixation option utilizing hybrid technology, expected to be fully commercialized in the second half of 2026 [4]. - The Lapiplasty Lightning System is designed for greater accuracy and control in 3D correction, with full commercialization anticipated in late 2026 [4]. - Nanoplasty and Percuplasty are minimally invasive systems designed for efficient access to 3D osteotomies, with unique features to enhance surgical precision and recovery [4]. Clinical Study Presentations - The ALIGN3D clinical study will present interim data showing early return to weight bearing at an average of 8.4 days and low recurrence rates of 8.4% at 48 months [5][6]. - The MTA3D clinical study will present interim analysis demonstrating significant improvements in radiographic measures and patient-reported outcomes through 24 months [12]. - A retrospective study on the SpeedMTP system will show early return to weight bearing at an average of 3.7 days, with full radiographic union achieved in all patients at 6 months [8]. Company Overview - Treace Medical Concepts aims to advance the standard of care for bunion and midfoot deformities, addressing a significant market with approximately 67 million affected Americans, of which 1.1 million are surgical candidates annually [14]. - The company has developed the Lapiplasty 3D Bunion Correction System, which corrects bunion deformities in all three planes and secures the unstable joint, facilitating patient recovery [14].

Core Insights - Treace Medical Concepts, Inc. will release its financial results for Q3 2025 on November 6, 2025, after market close, followed by a conference call at 4:30 pm ET to discuss the results [1] Company Overview - Treace Medical Concepts is focused on advancing surgical treatment standards for bunions and related midfoot deformities, affecting approximately 65 million Americans, with an estimated 1.1 million being surgical candidates annually [4] - The company has developed the patented Lapiplasty 3D Bunion Correction System, which addresses the root cause of bunions by correcting deformities in three planes and stabilizing the affected joint [4] - Treace has introduced additional systems such as the Adductoplasty Midfoot Correction System, SpeedMTP Rapid Compression Implant, and minimally invasive options like the Nanoplasty and Percuplasty systems to cater to various surgical needs [4] - The company is expanding its presence in the foot and ankle market with innovative products like the SpeedPlate Rapid Compression Implants, which offer versatility across multiple surgical procedures [4]

Core Insights - Treace Medical Concepts, Inc. is set to release its financial results for Q2 2025 on August 7, 2025, after market close, followed by a conference call at 4:30 pm ET to discuss the results [1] - The company specializes in medical technology aimed at improving surgical treatments for bunions and midfoot deformities, with innovative procedures like Lapiplasty and Adductoplasty [1][4] Company Overview - Treace Medical Concepts focuses on advancing surgical management standards for bunions, which affect approximately 67 million Americans, with an estimated 1.1 million being surgical candidates annually [4] - The company has developed the patented Lapiplasty® 3D Bunion Correction® System, which addresses the root cause of bunions by correcting deformities in three planes and stabilizing the affected joint [4] - Additional products include the Adductoplasty® Midfoot Correction System, SpeedMTP™ Rapid Compression Implant, and systems for minimally invasive surgeries, expanding Treace's presence in the foot and ankle market [4]